| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 321-329, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Ruck, JC Xiao and E Kaiserling
Institute of Pathology, University of Tubingen, Germany.
The wide range of epithelial and mesenchymal lines of differentiation seen in hepatoblastoma suggests that this tumor derives from a pluripotent stem cell. To test this hypothesis, seven hepatoblastomas of various subtypes were investigated for the presence of cells with the features of the oval cells found during hepatocarcinogenesis in rodents that are thought to be closely related to hepatic stem cells. Because similar cells, referred to as "small cells," have been described in human liver disease with chronic ductular reaction, five liver biopsies from infants with biliary atresia were also investigated. The specimens were investigated by electron microscopy, immunoelectron microscopy, and immunostaining for cytokeratins 7, 8, 18, and 19. Small epithelial cells (SEC) corresponding to the oval cells of the rat and the "small cells" in humans were found in both biliary atresia and hepatoblastoma. These cells were oval and exhibited intercellular junctions, tonofilament bundles, and a biliary epithelium- type cytokeratin profile. SEC were found in small numbers in fetal hepatoblastoma and in moderate numbers in embryonal hepatoblastoma. In small cell hepatoblastoma, nearly all the tumor cells exhibited SEC- like ultrastructural features and a corresponding cytokeratin profile. Thus, cells exhibiting morphological and immunophenotypic features of hepatic stem cells are detectable in hepatoblastoma. Their numbers vary according to the subtype, reflecting the differing degrees of differentiation of the various subtypes, consistent with the theory propounded in the literature that embryonal and, with further differentiation, fetal tumor cells derive from precursor small cells. The findings support the hypothesis that hepatoblastoma derives from a pluripotent, probably entodermal or even less committed, stem cell.
This article has been cited by other articles:
![]() |
H. C. Fiegel, S. Gluer, B. Roth, J. Rischewski, D. von Schweinitz, B. Ure, W. Lambrecht, and D. Kluth Stem-like Cells in Human Hepatoblastoma J. Histochem. Cytochem., November 1, 2004; 52(11): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Fontes and A. W Thomson Stem cell technology BMJ, November 13, 1999; 319(7220): 1308 - 1308. [Full Text] |
||||
![]() |
E. Komura, T. Matsumura, T. Kato, T. Tahara, Y. Tsunoda, and T. Sawada Thrombopoietin in Patients with Hepatoblastoma Stem Cells, September 1, 1998; 16(5): 329 - 333. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |